Trends in Incidence and Clinical Outcomes of Clostridioides Difficile Infection, Hong Kong

Overview

Journal Emerg Infect Dis

Specialty Infectious Diseases

Date 2021 Nov 23

PMID 34812719

Citations 5

Authors

Cosmos L T Guo

Thomas N Y Kwong

Joyce W Y Mak

Lin Zhang

Grace C Y Lui

Grace L H Wong

Margaret Ip

Jun Yu

Joseph J Y Sung

William K K Wu

Sunny H Wong

Affiliations

Soon will be listed here.

Citing Articles

Molecular characteristics, clonal transmission, and risk factors of among hospitalized patients in a tertiary hospital in Ningbo, China.

Hu L, Lin S, Zhang M, Cai M, Shen Y, Zeng P Front Microbiol. 2024; 15:1507128.

PMID: 39687873 PMC: 11648312. DOI: 10.3389/fmicb.2024.1507128.

The Prevalence and Risk Factors of Infection in Inflammatory Bowel Disease: 10-Year South Korean Experience Based on the National Database.

Song E, Choi A, Kim S, Jung S J Korean Med Sci. 2023; 38(47):e359.

PMID: 38050911 PMC: 10695757. DOI: 10.3346/jkms.2023.38.e359.

The evaluation of different types fecal bacteria products for the treatment of recurrent associated diarrhea: A systematic review and network meta-analysis.

Yang L, Li W, Zhang X, Tian J, Ma X, Han L Front Surg. 2022; 9:927970.

PMID: 36468073 PMC: 9709817. DOI: 10.3389/fsurg.2022.927970.

Comparing the impact of two contact isolation modes for hospitalised patients with Clostridioides difficile infection on the quality of care.

Gehasi I, Livshiz-Riven I, Michael T, Borer A, Saidel-Odes L J Clin Nurs. 2022; 32(5-6):872-878.

PMID: 35761758 PMC: 10084440. DOI: 10.1111/jocn.16416.

Infection in Liver Cirrhosis: A Concise Review.

Liu Y, Chen M Can J Gastroenterol Hepatol. 2022; 2022:4209442.

PMID: 35711246 PMC: 9197604. DOI: 10.1155/2022/4209442.

References

Tariq R, Cho J, Kapoor S, Orenstein R, Singh S, Pardi D . Low Risk of Primary Clostridium difficile Infection With Tetracyclines: A Systematic Review and Metaanalysis. Clin Infect Dis. 2018; 66(4):514-522. DOI: 10.1093/cid/cix833. View

Ofori E, Ramai D, Dhawan M, Mustafa F, Gasperino J, Reddy M . Community-acquired Clostridium difficile: epidemiology, ribotype, risk factors, hospital and intensive care unit outcomes, and current and emerging therapies. J Hosp Infect. 2018; 99(4):436-442. DOI: 10.1016/j.jhin.2018.01.015. View

Wong S, Ip M, Hawkey P, Lo N, Hardy K, Manzoor S . High morbidity and mortality of Clostridium difficile infection and its associations with ribotype 002 in Hong Kong. J Infect. 2016; 73(2):115-22. DOI: 10.1016/j.jinf.2016.05.010. View

Collins D, Riley T . in Asia: Opportunities for One Health Management. Trop Med Infect Dis. 2019; 4(1). PMC: 6473466. DOI: 10.3390/tropicalmed4010007. View

Leffler D, Lamont J . Clostridium difficile infection. N Engl J Med. 2015; 372(16):1539-48. DOI: 10.1056/NEJMra1403772. View

Liao F, Li W, Gu W, Zhang W, Liu X, Fu X . A retrospective study of community-acquired Clostridium difficile infection in southwest China. Sci Rep. 2018; 8(1):3992. PMC: 5838233. DOI: 10.1038/s41598-018-21762-7. View

Rizzardi K, Noren T, Aspevall O, Makitalo B, Toepfer M, Johansson A . National Surveillance for Clostridioides difficile Infection, Sweden, 2009-2016. Emerg Infect Dis. 2018; 24(9):1617-1625. PMC: 6106436. DOI: 10.3201/eid2409.171658. View

Cohen S, Gerding D, Johnson S, Kelly C, Loo V, McDonald L . Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010; 31(5):431-55. DOI: 10.1086/651706. View

Chow V, Kwong T, So E, Ho Y, Wong S, Lai R . Surveillance of antibiotic resistance among common Clostridium difficile ribotypes in Hong Kong. Sci Rep. 2017; 7(1):17218. PMC: 5722880. DOI: 10.1038/s41598-017-17523-7. View

10.

Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, Ghali W . New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol. 2004; 57(12):1288-94. DOI: 10.1016/j.jclinepi.2004.03.012. View

11.

Imwattana K, Knight D, Kullin B, Collins D, Putsathit P, Kiratisin P . ribotype 017 - characterization, evolution and epidemiology of the dominant strain in Asia. Emerg Microbes Infect. 2019; 8(1):796-807. PMC: 6542179. DOI: 10.1080/22221751.2019.1621670. View

12.

Ng S, Leung W, Shi H, Li M, Leung C, Ng C . Epidemiology of Inflammatory Bowel Disease from 1981 to 2014: Results from a Territory-Wide Population-Based Registry in Hong Kong. Inflamm Bowel Dis. 2016; 22(8):1954-60. DOI: 10.1097/MIB.0000000000000846. View

13.

Lui R, Wong S, Lau L, Chan T, Cheung K, Li A . Faecal microbiota transplantation for treatment of recurrent or refractory infection in Hong Kong. Hong Kong Med J. 2019; 25(3):178-182. DOI: 10.12809/hkmj197855. View

14.

Kong K, Kwong T, Chan H, Wong K, Wong S, Chaparala A . Biological characteristics associated with virulence in ribotype 002 in Hong Kong. Emerg Microbes Infect. 2020; 9(1):631-638. PMC: 7144233. DOI: 10.1080/22221751.2020.1739564. View

15.

Heimann S, Cruz Aguilar M, Mellinghof S, Vehreschild M . Economic burden and cost-effective management of Clostridium difficile infections. Med Mal Infect. 2018; 48(1):23-29. DOI: 10.1016/j.medmal.2017.10.010. View

16.

Valiente E, Cairns M, Wren B . The Clostridium difficile PCR ribotype 027 lineage: a pathogen on the move. Clin Microbiol Infect. 2014; 20(5):396-404. DOI: 10.1111/1469-0691.12619. View

17.

Collins D, Sohn K, Wu Y, Ouchi K, Ishii Y, Elliott B . infection in the Asia-Pacific region. Emerg Microbes Infect. 2019; 9(1):42-52. PMC: 6968625. DOI: 10.1080/22221751.2019.1702480. View

18.

Gupta A, Khanna S . Community-acquired Clostridium difficile infection: an increasing public health threat. Infect Drug Resist. 2014; 7:63-72. PMC: 3962320. DOI: 10.2147/IDR.S46780. View

19.

Guh A, Mu Y, Winston L, Johnston H, Olson D, Farley M . Trends in U.S. Burden of Infection and Outcomes. N Engl J Med. 2020; 382(14):1320-1330. PMC: 7861882. DOI: 10.1056/NEJMoa1910215. View

20.

Ho J, Dai R, Kwong T, Wang X, Zhang L, Ip M . Disease Burden of Clostridium difficile Infections in Adults, Hong Kong, China, 2006-2014. Emerg Infect Dis. 2017; 23(10):1671-1679. PMC: 5621553. DOI: 10.3201/eid2310.170797. View